MICroSTREP Panel, New Strep Testing Procedure Cleared by FDA
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




MICroSTREP Panel, New Strep Testing Procedure Cleared by FDA

WEST SACRAMENTO, Calif.—Dec. 26, 1996 -- Dade MicroScan Inc. has received FDA clearance for the Dade MICroSTREP(TM) Panel, a new testing procedure for antimicrobial susceptibility of three different classes of streptococcus including Streptococcus pneumoniae, viridans streptococci and beta-hemolytic streptococci.

The new Dade procedure tests all major non-enterococcal streptococci with a single panel. The frozen microdilution technique of the Dade MICroSTREP Panel follows NCCLS guidelines and offers greater than 99% agreement without limitations to the NCCLS reference method.

This procedure also is the only broth microdilution panel that incorporates the new NCCLS M100-S6 endpoints.

The new method of testing includes all NCCLS-recommended primary antimicrobics on one panel. These ten antimicrobial agents provide more diagnostic information in a single procedure than has been previously available.

"Streptococcal isolates that are resistant to traditional antimicrobial therapy are being more frequently reported by clinicians," according to John Groat, marketing manager at Dade MicroScan. "The need for susceptibility testing to determine alternative treatments has never been greater," adds Groat.

The Dade MICroSTREP Panel offers clear and concise endpoints which provide a definitive MIC value. The panels, which can be read manually in any microbiology lab, increase accuracy by reducing operator error.

Dade MicroScan, Inc., a division of Dade International, is headquartered in West Sacramento and is a leader in microbiology identification and antibiotic susceptibility testing.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities